Sapna Shah-Haque
Internal Medicine · Winfield, KSNPI 1881906592
Payments from drug & device makers
Across 90 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$391
- Novo Nordisk$248
- Lilly USA, LLC$192
- Amgen$92
- Sanofi-aventis U.S. LLC$86
- Lundbeck LLC$69
- plus $458 from 19 others
What the payments were for
- Food & beverage$1,536100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $391 |
| Novo Nordisk | 14 | $248 |
| Lilly USA, LLC | 13 | $192 |
| Amgen | 5 | $92 |
| Sanofi-aventis U.S. LLC | 5 | $86 |
| Lundbeck LLC | 3 | $69 |
| Insulet Corporation | 3 | $67 |
| Pfizer | 4 | $54 |
| Boehringer Ingelheim | 3 | $50 |
| Bayer | 2 | $34 |
| Johnson & Johnson | 2 | $28 |
| Mylan Specialty L.p. | 2 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Mirum Pharmaceuticals, Inc. | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Abbott | 1 | $14 |
| GSK | 1 | $14 |
| Merck | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Exact Sciences | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$1,536 in reported general payments places this provider in the 80th percentile of 705 internal medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 86 | $62,630 |
| OzempicSemaglutide | 27 | $27,467 |
| TrulicityDulaglutide | 20 | $24,486 |
| XareltoRivaroxaban | 30 | $22,373 |
| JardianceEmpagliflozin | 26 | $20,653 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 19 | $18,480 |
| MyrbetriqMirabegron | 15 | $6,668 |
| Advair HfaFluticasone Propion/Salmeterol | 19 | $5,955 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $4,848 |
| SynthroidLevothyroxine Sodium | 51 | $3,423 |
| Gabapentin | 189 | $3,351 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 11 | $3,263 |
| Levothyroxine Sodium | 328 | $2,548 |
| Novolog FlexpenInsulin Aspart | 19 | $2,353 |
| Pantoprazole Sodium | 201 | $2,262 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $54 | $62,63086 claims |
| Novo NordiskOzempic | $248 | $27,46727 claims |
| Lilly USA, LLCTrulicity | $192 | $24,48620 claims |
| Johnson & JohnsonXarelto | $28 | $22,37330 claims |
| Boehringer IngelheimJardiance | $50 | $20,65326 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $86 | $18,48019 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $13 | $1,99012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 705 internal medicine providers in Kansas.
Other internal medicine in Winfield
- Martin KankamLeavenworth$63.4M
- Mark HamblinKansas City$5.2M
- Katherine WillinghamTopeka$4.8M
- Raed Al RajabiWestwood$4.5M
- Leslie SpikesKansas City$4.5M
- Michael CoxTopeka$3.4M
- James RuhlmannHutchinson$2.8M
- Scott TeeterTopeka$1.2M
- Shadi HamdehKansas City$1.1M
- Kyle WorkKansas City$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.